Daily as of 3 Nov 16:00 ET
- Price
- below both $9.75 vs 50 $12.32 / 200 $10.44
- Projection
- 💀Death cross estimated in 13 to 19 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 5 Sep 2025 · projected 29 bars out
CLYM | Climb BioNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$9.75
+$0.01 (+0.10%)
Climb Bio (CLYM) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2025.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Sep 2025, but the two have been closing on each other and a death cross is projected within 20 bars. Price sits below the 50 and the 200 on the daily and the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 16:00 ET
- Price
- below both $9.75 vs 50 $10.45 / 200 $12.87
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 9 Oct 2026 · projected 26 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 9 Oct 2026 | 💀Death | 4-hour | 26 bars out | Not tested |
| 5 Sep 2025 | 🟨Golden steep | daily | 29 bars out | Not tested |
About CLYM
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$16.4M
4-hour coverageYes, since Oct 2025
History on recordSince 2025
SectorHealthcare
Cap bandsmall